Sickle cell maculopathy
1 October 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
OCT imaging, Sickle cell disease, Sickle cell maculopathy, Visual impairment
This paper reports the result of a prospective study to analyse the prevalence of sickle cell maculopathy (SCM) and its associations with age, sex, genotype, proliferative sickle cell retinopathy (PSR) stage, and the impact on visual acuity (VA). This study...
Risk factors and prognosis of paediatric open globe injuries
1 October 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Choroidal damage, Endophthalmitis, No light perception, Pediatric open globe injuries, Vitreoretinal surgery
This retrospective, comparative, interventional case-control study was aimed to investigate possible risk factors and prognosis of initial no light perception (NLP) in paediatric open globe injuries (POGI). A total of 851 cases were reviewed, including 837 unilateral cases and 14...
Outcomes of treat & extend ranibizumab in diabetic macular oedema
1 October 2021
| Ed Rule
|
EYE - Vitreo-Retinal
|
Diabetic macular edema, Outcome predictor, Ranibizumab, Spectral-domain optical coherence tomography, Treat and extend
This study retrospectively evaluated 118 eyes of 87 patients who received ranibizumab in a treat and extend regimen for diabetic macular oedema (DMO). Data were collected for patients under follow-up for 24 months. After 24 months, patients gained a mean...
Evaluation of Optive® in ocular discomfort after anti-VEGF intravitreal injection
1 October 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Artificial tear, Intravitreal injection therapy, Ocular discomfort, Ocular surface
In this study the authors prospectively evaluated the efficacy of Optive® eye drops after in full, then abbreviation - intravitreal injection (IVT). Patients naïve to IVT were included in the study. No artificial tear treatment was prescribed after the first...
Steroid treatment for pseudophakic cystoid macular oedema
1 October 2021
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Cystoid macular edema, intravitreal steroids, triamcinolone
The authors present a retrospective comparison of 45 eyes of 41 patients treated with 2mg intravitreal triamcinolone (IVT group) and 50 eyes of 42 patients treated with 40mg sub-Tenons triamcinolone (STT group) for pseudophakic cystoid macular oedema (CMO). The visual...
Anything new in the control of myopia progression?
1 October 2021
| Zhihang Cheng
|
EYE - Vitreo-Retinal
|
Axial length, Children, Efficacy, Myopia, Myopia control, Retinal disease
This is a review article looking at up to date concepts and evidence in myopia control from current literature and studies. The authors identified that myopia control is best measured in absolute change in axial length as opposed to refraction...
Transient macular thinning with Densiron 68
4 August 2021
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
OCT, Retinal detachment, heavy silicone oil, macula
Densiron 68 is a heavy silicone oil (HSO) used to treat rhegmatogenous retinal detachments (RRD) with inferior retinal breaks. The authors compared changes in retinal thickness during and after the use of Densiron endotamponade, and looked at any association between...
Visual outcomes after surgery for primary rhegmatogenous retinal detachment in era of microincision vitrectomy
This is a prospective, multicentre, nationwide study between 2016 and 2017, to investigate the preoperative ocular factors, surgical techniques (pars plana vitrectomy (PPV) or scleral buckling (SB), or combined procedures) for rhegmatogenous retinal detachment (RRD) and postoperative best corrected visual...
Subconjunctival anaesthesia in vitreoretinal surgery
4 August 2021
| Ed Rule
|
EYE - Vitreo-Retinal
|
Peribulbar anesthesia, Retrobulbar anesthesia, Two-step anesthesia, Vitrectomy
The authors present a technique that combines topical and subconjunctival anaesthesia for vitreoretinal surgery. In this ‘two-step’ procedure, three drops of proparacaine were applied to the conjunctival fornix, followed by subconjunctival lidocaine injected in three quadrants. This was compared with...
The effects of anti-VEGF therapy for NvAMD on retinal vasculature
4 August 2021
| Su Young
|
EYE - Vitreo-Retinal
|
aflibercept, foveal avascular zone, neovascular age-related macular degeneration, ranibizumab, retinal vessel density
This retrospective consecutive case series examined 54 eyes of 54 treatment-naïve neovascular age-related macular degeneration (N-AMD) patients. Thirty-three eyes received intravitreal aflibercept injections, and 21 eyes received intravitreal ranibizumab injections with unaffected fellow eyes (54 eyes) as controls. All image...
OCTA in geographic atrophy
4 August 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Age-related macular degeneration, Angiography, Choriocapillaris, Choroid, Optical coherence tomography
In this article the authors aim to give an overview of the current literature concerning the application of OCT-A in geographic atrophy (GA). GA is a disease characterised by loss of outer retinal layers including photoreceptors, degeneration of the retinal...
Control of diabetic retinopathy after bariatric surgery
3 June 2021
| Tasmin Berman
|
EYE - Vitreo-Retinal
This systemic review and meta-analysis assessed prevalence of diabetic retinopathy including sight-threatening diabetic retinopathy after surgery. They included 14 studies with 110,300 surgical patients and 252,289 control subjects. They proposed that the risk of having any form of diabetic retinopathy...
